2023
DOI: 10.1016/j.mce.2022.111784
|View full text |Cite
|
Sign up to set email alerts
|

20-HETE/GPR75 pairing modulates the expression and transcriptional activity of the androgen receptor in androgen-sensitive prostate cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…Commercially available antibodies for GPR75 were first tested. None of the commercially available antibodies tested, including antibodies used in previous studies (Cardenas et al, 2020, 2023; Dedoni et al, 2018; Gonzalez‐Fernandez et al, 2020), demonstrated specificity for GPR75 (Figure S1). Some commercial antibodies used in previous studies were no longer available and therefore could not be tested (Garcia et al, 2017; Liu et al, 2013).…”
Section: Resultsmentioning
confidence: 93%
“…Commercially available antibodies for GPR75 were first tested. None of the commercially available antibodies tested, including antibodies used in previous studies (Cardenas et al, 2020, 2023; Dedoni et al, 2018; Gonzalez‐Fernandez et al, 2020), demonstrated specificity for GPR75 (Figure S1). Some commercial antibodies used in previous studies were no longer available and therefore could not be tested (Garcia et al, 2017; Liu et al, 2013).…”
Section: Resultsmentioning
confidence: 93%